An investigator reported 10-year follow-up data from a phase 3 trial of extended vs limited pelvic lymph node dissection during radical prostatectomy.

The FDA has granted Priority Review to finerenone (Kerendia) for adults with type 1 diabetes and CKD, following FINE-ONE trial data showing a 25% reduction in UACR.

Genitourinary adverse events seen in both groups; similarly, very low rates of gastrointestinal adverse events seen with 2F SBRT, 5F SBRT.

For physicians who have left clinical practice, hassle factor and too stressful are prime motivations for departure, according to a study published online May 7 in The Permanente Journal. Sea Chen, M.

The FDA is reviewing an sBLA for nogapendekin alfa inbakicept-pmln plus BCG to treat BCG-unresponsive NMIBC with papillary disease without CIS.